LifeVantage Corporation

LFVN

US53222K2050

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 11:47:02 16/07/2024 pm IST			5-day change	1st Jan Change
6.13 ^USD	-2.08%		+11.01%	+4.17%

02/05	Earnings Flash (LFVN) LIFEVANTAGE CORPORATION Reports Q3 Revenue $48.2M, vs. Street Est of $52.2M	MT
02/05	Transcript : LifeVantage Corporation, Q3 2024 Earnings Call, May 02, 2024

LifeVantage Corporation Appoints Charles J. Wach as Chief Operating Officer, Effective March 13, 2017

March 09, 2017 at 07:30 pm IST

LifeVantage Corporation announced the appointment of Charles J. Wach as chief operating officer, effective March 13, 2017. Most recently, Mr. Wach served as vice president of operations and supply chain executive for Bodybuilding.com Inc. from 2013 to 2017.

Latest news about LifeVantage Corporation

Earnings Flash (LFVN) LIFEVANTAGE CORPORATION Reports Q3 Revenue $48.2M, vs. Street Est of $52.2M	03/05	MT
Transcript : LifeVantage Corporation, Q3 2024 Earnings Call, May 02, 2024	03/05
Earnings Flash (LFVN) LIFEVANTAGE CORPORATION Reports Q3 EPS $0.21, vs. Street Est of $0.16	03/05	MT
LifeVantage Corporation Declares Quarterly Dividend, Payable on June 14, 2024	03/05	CI
Tranche Update on LifeVantage Corporation's Equity Buyback Plan announced on November 27, 2017.	03/05	CI
LifeVantage Corporation Revises Earnings Guidance for the Fiscal Year 2024	03/05	CI
LifeVantage Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	03/05	CI
LifeVantage Corporation Enters Loan Agreement with Bank of America, N.A	17/04	CI
Transcript : LifeVantage Corporation - Special Call	20/03
LifeVantage Corporation Announces the Launch of its TrueScience Activated Skin Care Collection	04/03	CI
Bradley Louis Radoff and Sudbury Capital Management Enter into Cooperation Agreement with LifeVantage Corporation	16/02	CI
LifeVantage Corporation Appoints Dayton Judd to Its Board of Directors, Audit Committee and the Nominating and Corporate Governance Committee	16/02	CI
LifeVantage Corporation Announces Expansion of LV360 into Canada, Mexico, and European Markets	07/02	CI
Lifevantage Keeps Quarterly Cash Dividend at $0.035 a Share, Payable March 15 to Holders of Record March 1	31/01	MT
Transcript : LifeVantage Corporation, Q2 2024 Earnings Call, Jan 30, 2024	31/01
Earnings Flash (LFVN) LIFEVANTAGE CORPORATION Reports Q2 Revenue $51.6M, vs. Street Est of $54.6M	31/01	MT
Earnings Flash (LFVN) LIFEVANTAGE CORPORATION Reports Q2 EPS $0.10	31/01	MT
LifeVantage Corporation Provides Earnings Guidance for the Fiscal Year 2024	31/01	CI
Tranche Update on LifeVantage Corporation's Equity Buyback Plan announced on November 27, 2017.	31/01	CI
LifeVantage Corporation Declares Quarterly Dividend, Payable on March 15, 2024	31/01	CI
LifeVantage Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	31/01	CI
Key Inflation Data Awaited as Exchange-Traded Funds, Equity Futures Rise Pre-Bell Thursday	30/11	MT
Lifevantage Says Protandim Nrf2-TrueScience Combination Helps Cells 'Accurately' Respond To Stress Levels	30/11	MT
LifeVantage Corporation Announces Executive Changes	28/11	CI
Bradley Louis Radoff and Sudbury Capital Management?s Counsel Delivers a Letter to Counsel to LifeVantage Corporation	15/11	CI

Chart LifeVantage Corporation

Duration

Period

More charts

Company Profile

LifeVantage Corporation is engaged in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. The Company's dietary supplements include its flagship Protandim family of products, LifeVantage Omega+, ProBio, IC Bright, and Daily Wellness dietary supplements. The Protandim product line includes Protandim NRF1 Synergizer, Protandim Nrf2 Synergizer, and Protandim NAD Synergizer. TrueScience is its line of skin, hair, bath and body, and targeted relief products. The Company also markets and sells Petandim, its companion pet supplement formulated to combat oxidative stress in dogs; Axio, its nootropic energy drink mixes, and PhysIQ, its smartweight management system, which includes PhysIQ Fat Burn and PhysIQ Prebiotic, all formulated to aid in weight management.

Sector

Pharmaceuticals

Calendar

14/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
LIFEVANTAGE CORPORATION	+4.17%	7.95Cr
ELI LILLY AND COMPANY	+62.30%	86TCr
NOVO NORDISK A/S	+38.95%	63TCr
JOHNSON & JOHNSON	-3.97%	36TCr
MERCK & CO., INC.	+15.76%	32TCr
ABBVIE INC.	+8.89%	30TCr
ROCHE HOLDING AG	+5.89%	23TCr
NOVARTIS AG	+16.53%	23TCr
AMGEN INC.	+16.03%	18TCr
PFIZER, INC.	+2.17%	16TCr

Other Pharmaceuticals